The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass

BackgroundThe sivelestat is a neutrophil elastase inhibitor thought to have an effect against acute lung injury (ALI) in patients after scheduled cardiac surgery. However, the beneficial effect of sivelestat in patients undergoing emergent cardiovascular surgery remains unclear. We aim to evaluate t...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Frontiers in Immunology
المؤلفون الرئيسيون:	Tuo Pan, Tayierjiang Tuoerxun, Xi Chen, Cheng-Jin Yang, Chen-Yu Jiang, Yi-Fan Zhu, Ze-Shi Li, Xin-Yi Jiang, Hai-Tao Zhang, He Zhang, Ya-Peng Wang, Wei Chen, Li-Chong Lu, Min Ge, Yong-Qing Cheng, Dong-Jin Wang, Qing Zhou
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Frontiers Media S.A. 2023-01-01
الموضوعات:	sivelestat cardiopulmonary bypass acute lung injury cardiovascular surgery outcomes
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1082830/full